Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Thomas, Starkey"'
Autor:
Thomas Starkey, Maria C. Ionescu, Michael Tilby, Martin Little, Emma Burke, Matthew W. Fittall, Sam Khan, Justin K. H. Liu, James R. Platt, Rosie Mew, Arvind R. Tripathy, Isabella Watts, Sophie Therese Williams, Nathan Appanna, Youssra Al-Hajji, Matthew Barnard, Liza Benny, Alexander Burnett, Jola Bytyci, Emma L. Cattell, Vinton Cheng, James J. Clark, Leonie Eastlake, Kate Gerrand, Qamar Ghafoor, Simon Grumett, Catherine Harper-Wynne, Rachel Kahn, Alvin J. X. Lee, Oliver Lomas, Anna Lydon, Hayley Mckenzie, NCRI Consumer Forum, Hari Panneerselvam, Jennifer S. Pascoe, Grisma Patel, Vijay Patel, Vanessa A. Potter, Amelia Randle, Anne S. Rigg, Tim M. Robinson, Rebecca Roylance, Tom W. Roques, Stefan Rozmanowski, René L. Roux, Ketan Shah, Remarez Sheehan, Martin Sintler, Sanskriti Swarup, Harriet Taylor, Tania Tillett, Mark Tuthill, Sarah Williams, Yuxin Ying, Andrew Beggs, Tim Iveson, Siow Ming Lee, Gary Middleton, Mark Middleton, Andrew Protheroe, Tom Fowler, Peter Johnson, Lennard Y. W. Lee
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Patients with cancer are at increased risk of hospitalisation and mortality following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, the SARS-CoV-2 phenotype evolution in patients with cancer since 2020 has
Externí odkaz:
https://doaj.org/article/b2a7d9f7273c4fa49fa236821ef7154d
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background Lateral flow devices (LFDs) are viral antigen tests for the detection of SARS-CoV-2 that produce a rapid result, are inexpensive and easy to operate. They have been advocated for use by the World Health Organisation to help contro
Externí odkaz:
https://doaj.org/article/8ec450a7d5684707b1425acf1fcf74a1
Autor:
Lennard Y. W. Lee, Thomas Starkey, Shivan Sivakumar, Susan Fotheringham, Guy Mozolowski, Vanessa Shearwood, Claire Palles, Philip Camilleri, David Church, Rachel Kerr, David Kerr
Publikováno v:
Cancer Medicine, Vol 8, Iss 14, Pp 6305-6314 (2019)
Abstract Introduction In this study (PRECISE), we assess the clinical utility of a germline DNA sequencing‐based test (ToxNav) for mutations in DPYD and ENOSF1 genes to alter clinician‐prescribed fluoropyrimidine doses and the use of a digital ap
Externí odkaz:
https://doaj.org/article/63331bd09b3348e393f3e083b2d7ea93
Autor:
Rhea Suribhatla, Thomas Starkey, Maria C. Ionescu, Antonio Pagliuca, Alex Richter, Lennard Y. W. Lee
Publikováno v:
British Journal of Haematology. 201:813-823
Publikováno v:
JAMA Oncology.
Publikováno v:
Rheumatology. 62
Background/Aims Immunocompromised patients have a reduced ability to generate antibodies after COVID-19 vaccination, and are at a high risk of SARS-CoV-2 infection, complications and mortality. Tixagevimab/Cilgavimab (Evusheld) is a combination of tw
Autor:
Ian Tomlinson, Shazia Irshad, Stefania Segditsas, Chiara Bardella, Tia Mirshahi, Sujata Biswas, Thomas Starkey, Connor Woolley, Lennard Y.W. Lee
Purpose:The molecular events that determine intestinal cell differentiation are poorly understood and it is unclear whether it is primarily a passive event or an active process. It is clinically important to gain a greater understanding of the proces
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5527632899eac34ae2404213d3c9974f
https://doi.org/10.1158/1078-0432.c.6529032
https://doi.org/10.1158/1078-0432.c.6529032
Autor:
Ian Tomlinson, Shazia Irshad, Stefania Segditsas, Chiara Bardella, Tia Mirshahi, Sujata Biswas, Thomas Starkey, Connor Woolley, Lennard Y.W. Lee
Supplementary Table 1. Differentially expressed genes from colonic crypt tops vs. bottoms of normal individuals (adjusted p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bea0aeccbf160beddb08a6404a21b2a9
https://doi.org/10.1158/1078-0432.22475289.v1
https://doi.org/10.1158/1078-0432.22475289.v1
Autor:
Rhea Suribhatla, Thomas Starkey, Maria C Ionescu, Antonio Pagliuca, Alex Richter, Lennard YW Lee
Background and aimsImmunocompromised patients have a reduced ability to generate antibodies after COVID-19 vaccination and are at higher risk of SARS-CoV-2 infection, complications and mortality. Tixagevimab/Cilgavimab (Evusheld) is a monoclonal anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b46ba545f61b904774797691071d4810
https://doi.org/10.1101/2022.11.07.22281786
https://doi.org/10.1101/2022.11.07.22281786
Autor:
Lennard Y.W. Lee, Maria C. Ionescu, Thomas Starkey, Martin Little, Michael Tilby, Arvind R. Tripathy, Hayley S. Mckenzie, Youssra Al-Hajji, Nathan Appanna, Matthew Barnard, Liza Benny, Alexander Burnett, Emma L. Cattell, James J. Clark, Sam Khan, Qamar Ghafoor, Hari Panneerselvam, George Illsley, Catherine Harper-Wynne, Rosie J. Hattersley, Alvin JX. Lee, Oliver Lomas, Justin KH. Liu, Amanda McCauley, Matthew Pang, Jennifer S. Pascoe, James R. Platt, Grisma Patel, Vijay Patel, Vanessa A. Potter, Amelia Randle, Anne S. Rigg, Tim M. Robinson, Tom W. Roques, René L. Roux, Stefan Rozmanowski, Harriet Taylor, Mark H. Tuthill, Isabella Watts, Sarah Williams, Andrew Beggs, Tim Iveson, Siow M. Lee, Gary Middleton, Mark Middleton, Andrew Protheroe, Matthew W. Fittall, Tom Fowler, Peter Johnson, Emma Kinloch, Emily Lam, Gillian Murphy, Malcolm Rhodes, Kate Robinson, Sanskriti Swarup, Keeley Bernhardt, Jola Bytyci, Yuxin Ying, Sukhmunni Johal, Remarez Sheehan
Publikováno v:
European journal of cancer (Oxford, England : 1990). 175
People living with cancer and haematological malignancies are at an increased risk of hospitalisation and death following infection with acute respiratory syndrome coronavirus 2. Coronavirus third dose vaccine boosters are proposed to boost waning im